Enhanced Treatment of Liver Carcinoma with a Catheter-Administered or Injectable Drug-Eluting Hydrogel (IMAGE)

Terasaki Institute for Biomedical Innovation

Enhanced Treatment of Liver Carcinoma with a Catheter-Administered or Injectable Drug-Eluting Hydrogel

Caption

Scientists from the Terasaki Institute for Biomedical Innovation (TIBI) have developed an injectable or catheter-administered hydrogel with enhanced capabilities for treating hepatocellular carcinoma, a deadly form of liver cancer.

Credit

Terasaki Institute for Biomedical Innovation

Usage Restrictions

Request permission from Terasaki Institute for Biomedical Innovation.

License

Original content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.